HVJ-E

AXP000130.1 · Oncolytic virus

Platform
Sendai virus envelope (UV-inactivated, non-replicating)
Originator
Osaka University (Yasufumi Kaneda)
Sponsor
GenomIdea

Names

NameTypeSource
HVJ-Epreferred name, codecurator, paper
GEN0101codepaper

Virus

Role
Other
Family
Paramyxoviridae
Virus
Sendai virus (NCBI Taxonomy 3052731)
Strain
HVJ (Z strain lineage), UV-inactivated envelope
Replication
non replicating
Modifications
UV-inactivated virions; genome replication-incompetent, envelope fusion retained
Route
intratumoral
Source
evidence

Approvals

No regulatory approval recorded.

Clinical trials (2)

TrialTitleStatusPhaseStartPrimary completionEnrolmentConditions
NCT03818893Combination Therapy With GEN0101 and Pembrolizmub in Advanced Melanoma Patients PIb/PIIUnknownPhase 22019-032021-12-3146Advanced Melanoma
NCT02502994Phase 1 Study of GEN0101 in Patients With Recurrence of CRPCUnknownPhase 12015-052016-1212Castration Resistant Prostate Cancer

Recent changes

No changes recorded in its trials yet.

Clinical papers

PubMedTitleJournalYearLinked by
PMID 39358654Dose-escalation, tolerability, and efficacy of intratumoral and subcutaneous injection of hemagglutinating virus of Japan envelope (HVJ-E) against chemotherapy-resistant malignant pleural mesothelioma: a clinical trial.Cancer immunology, immunotherapy : CII2024name in title: HVJ-E
PMID 34984539A phase I dose-escalation, safety/tolerability, and preliminary efficacy study of the intratumoral administration of GEN0101 in patients with advanced melanoma.Cancer immunology, immunotherapy : CII2022name in title: GEN0101
PMID 32112659Intratumoral and s.c. injection of inactivated hemagglutinating virus of Japan envelope (GEN0101) in metastatic castration-resistant prostate cancer.Cancer science2020name in title: GEN0101
PMID 28497777Phase I/II clinical trial to assess safety and efficacy of intratumoral and subcutaneous injection of HVJ-E in castration-resistant prostate cancer patients.Cancer gene therapy2017name in title: HVJ-E
Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 32047956Intratumoral injection of hemagglutinating virus of Japan-envelope vector yielded an antitumor effect for advanced melanoma: a phase I/IIa clinical study.Cancer immunology, immunotherapy : CII2020name in abstract: HVJ-E

Other papers

Preclinical studies, reviews and other papers that name it, newest 100 shown.

PubMedTitleJournalYearLinked by
PMID 42423067Exploring the potential of HVJ-E for cancer immunotherapy.Immunotherapy2026name in title: HVJ-E
PMID 40541272HVJ-E links Apolipoprotein d to antitumor effects.Journal for immunotherapy of cancer2025name in title: HVJ-E
PMID 38215278The press-assisted fusion scheme significantly mitigates the quantity of HVJ-E required in mitochondrial replacement techniques.Reproduction (Cambridge, England)2024name in title: HVJ-E
PMID 39534532Local treatment of HVJ-E with T cell costimulatory molecule stimulation elicits systemic anti-tumor effects.Molecular therapy. Oncology2024name in title: HVJ-E
PMID 33575480CXCL2 combined with HVJ-E suppresses tumor growth and lung metastasis in breast cancer and enhances anti-PD-1 antibody therapy.Molecular therapy oncolytics2021name in title: HVJ-E
PMID 31492206A Novel Cellular Imaging Method Using Hemagglutinating Virus of Japan-Envelope (HVJ-E) Vector and Magnetic Particle Imaging.Journal of nanoscience and nanotechnology2020name in title: HVJ-E
PMID 32705650Hemagglutinating Virus of Japan Envelope (HVJ-E)-Guided Gene Transfer to the Intestinal Epithelium.Methods in molecular biology (Clifton, N.J.)2020name in title: HVJ-E
PMID 30956733Boron-incorporating hemagglutinating virus of Japan envelope (HVJ-E) nanomaterial in boron neutron capture therapy.Science and technology of advanced materials2019name in title: HVJ-E
PMID 30534001ERK-mediated autophagy promotes inactivated Sendai virus (HVJ-E)-induced apoptosis in HeLa cells in an Atg3-dependent manner.Cancer cell international2018name in title: HVJ-E
PMID 26553555A biomimetic approach to hormone resistant prostate cancer cell isolation using inactivated Sendai virus (HVJ-E).Biomaterials science2016name in title: HVJ-E
PMID 28787810Inactivated Sendai Virus (HVJ-E) Immobilized Electrospun Nanofiber for Cancer Therapy.Materials (Basel, Switzerland)2015name in title: HVJ-E
PMID 23441859Nano-decoration of the Hemagglutinating Virus of Japan envelope (HVJ-E) using a layer-by-layer assembly technique.Langmuir : the ACS journal of surfaces and colloids2013name in title: HVJ-E
PMID 21900962The combination of chemotherapy with HVJ-E containing Rad51 siRNA elicited diverse anti-tumor effects and synergistically suppressed melanoma.Gene therapy2012name in title: HVJ-E
PMID 22727893HVJ-E/importin-β hybrid vector for overcoming cytoplasmic and nuclear membranes as double barrier for non-viral gene delivery.Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie2012name in title: HVJ-E
PMID 20730616Immunogene therapy using immunomodulating HVJ-E vector augments anti-tumor effects in murine malignant glioma.Journal of neuro-oncology2011name in title: HVJ-E
PMID 21444118Immunoadjuvant effects of hemagglutinating virus of Japan envelope (HVJ-E) on the inactivated H9 subtype avian influenza virus vaccine.Veterinary immunology and immunopathology2011name in title: HVJ-E
PMID 21982767Hemagglutinating virus of Japan envelope (HVJ-E) can enhance the immune responses of swine immunized with killed PRRSV vaccine.Biochemical and biophysical research communications2011name in title: HVJ-E
PMID 19830690Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ-E) or type I interferon.International journal of cancer2010name in title: HVJ-E
PMID 20338150Reprogramming of somatic cells induced by fusion of embryonic stem cells using hemagglutinating virus of Japan envelope (HVJ-E).Biochemical and biophysical research communications2010name in title: HVJ-E
PMID 21053301Efficient in vivo delivery of plasmids and oligonucleotides using hemagglutinating virus of Japan envelope (HVJ-E) vector in immunological disease models.Current protocols in immunology2010name in title: HVJ-E
PMID 17072578Needleless intranasal administration of HVJ-E containing allergen attenuates experimental allergic rhinitis.Journal of molecular medicine (Berlin, Germany)2007name in title: HVJ-E
PMID 17352194[GenomONE HVJ-E vector].Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme2007name in title: HVJ-E
PMID 17883878A new therapy for highly effective tumor eradication using HVJ-E combined with chemotherapy.BMC medicine2007name in title: HVJ-E
PMID 17961511Development of a transferrin receptor-targeting HVJ-E vector.Biochemical and biophysical research communications2007name in title: HVJ-E
PMID 16177820Liver-directed gene therapy of diabetic rats using an HVJ-E vector containing EBV plasmids expressing insulin and GLUT 2 transporter.Gene therapy2006name in title: HVJ-E
PMID 16134237Magnetic nanoparticles with surface modification enhanced gene delivery of HVJ-E vector.Biochemical and biophysical research communications2005name in title: HVJ-E
PMID 14630698Intrathecal injection of HVJ-E containing HGF gene to cerebrospinal fluid can prevent and ameliorate hearing impairment in rats.FASEB journal : official publication of the Federation of American Societies for Experimental Biology2004name in title: HVJ-E
Unconfirmed matches (73)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

PubMedTitleJournalYearLinked by
PMID 40690186Hemagglutinating virus of Japan envelope encapsulating microRNA-34a-5p robustly induces apoptosis of malignant meningioma cells by suppressing survivin.Journal of neuro-oncology2025name in abstract: HVJ-E
PMID 36765886Add-On Effect of Hemagglutinating Virus of Japan Envelope Combined with Chemotherapy or Immune Checkpoint Inhibitor against Malignant Pleural Mesothelioma: An In Vivo Study.Cancers2023name in abstract: HVJ-E
PMID 36564568DNA barcoding and gene expression recording reveal the presence of cancer cells with unique properties during tumor progression.Cellular and molecular life sciences : CMLS2022name in abstract: HVJ-E
PMID 36671464An In Vivo Screening Model for Investigation of Pathophysiology of Human Implantation Failure.Biomolecules2022name in abstract: HVJ-E
PMID 32592133Efficient photodynamic therapy against drug-resistant prostate cancer using replication-deficient virus particles and talaporfin sodium.Lasers in medical science2021name in abstract: HVJ-E
PMID 33155337Hemagglutinating virus of Japan-envelope containing programmed cell death-ligand 1 siRNA inhibits immunosuppressive activities and elicits antitumor immune responses in glioma.Cancer science2021name in abstract: HVJ-E
PMID 31383952Cancer immunotherapy using the Fusion gene of Sendai virus.Cancer gene therapy2020name in abstract: HVJ-E
PMID 30191468Inhibition of Neointima Hyperplasia, Inflammation, and Reactive Oxygen Species in Balloon-Injured Arteries by HVJ Envelope Vector-Mediated Delivery of Superoxide Dismutase Gene.Translational stroke research2019name in abstract: HVJ-E
PMID 32255916Photodynamic therapy by lysosomal-targeted drug delivery using talaporfin sodium incorporated into inactivated virus particles.Laser therapy2019name in abstract: HVJ-E
PMID 29757287Combinational Treatment of Trichostatin A and Vitamin C Improves the Efficiency of Cloning Mice by Somatic Cell Nuclear Transfer.Journal of visualized experiments : JoVE2018name in abstract: HVJ-E
PMID 29773091Inactivated Sendai Virus Induces ROS-dependent Apoptosis and Autophagy in Human Prostate Cancer Cells.Biomedical and environmental sciences : BES2018name in abstract: HVJ-E
PMID 27960629Preclinical study and clinical trial of a novel therapeutic vaccine against multi-drug resistant tuberculosis.Human vaccines & immunotherapeutics2017name in abstract: HVJ-E
PMID 28456782Salmonella mediated the hemagglutinating virus of Japan-envelope transfer suppresses tumor growth.Oncotarget2017name in abstract: HVJ-E
PMID 28587331Directly reprogramming fibroblasts into adipogenic, neurogenic and hepatogenic differentiation lineages by defined factors.Experimental and therapeutic medicine2017name in abstract: HVJ-E
PMID 28945328Inactivated Sendai virus particle upregulates cancer cell expression of intercellular adhesion molecule-1 and enhances natural killer cell sensitivity on cancer cells.Cancer science2017name in abstract: HVJ-E
PMID 29079353Photodynamic therapy using a cytotoxic photosensitizer porphyrus envelope that targets the cell membrane.Photodiagnosis and photodynamic therapy2017name in abstract: HVJ-E
PMID 26548591An RNA Molecule Derived From Sendai Virus DI Particles Induces Antitumor Immunity and Cancer Cell-selective Apoptosis.Molecular therapy : the journal of the American Society of Gene Therapy2016name in abstract: HVJ-E
PMID 27141155Effective photodynamic therapy in drug-resistant prostate cancer cells utilizing a non-viral antitumor vector (a secondary publication).Laser therapy2016name in abstract: HVJ-E
PMID 27145280Cytoplasmic calcium increase via fusion with inactivated Sendai virus induces apoptosis in human multiple myeloma cells by downregulation of c-Myc oncogene.Oncotarget2016name in abstract: HVJ-E
PMID 27259252Virus-stimulated neutrophils in the tumor microenvironment enhance T cell-mediated anti-tumor immunity.Oncotarget2016name in abstract: HVJ-E
PMID 28081748Inactivated Sendai virus induces apoptosis mediated by reactive oxygen species in murine melanoma cells.Biomedical and environmental sciences : BES2016name in abstract: HVJ-E
PMID 25315678Effective capture of proteins inside living cells by antibodies indirectly linked to a novel cell-penetrating polymer-modified protein A derivative.The FEBS journal2015name in abstract: HVJ-E
PMID 25952096Effects of ROCK inhibitor Y-27632 on cell fusion through a microslit.Biotechnology and bioengineering2015name in abstract: HVJ-E
PMID 26131319New model for cardiomyocyte sheet transplantation using a virus-cell fusion technique.World journal of stem cells2015name in abstract: HVJ-E
PMID 26235873Inactivated Sendai virus induces apoptosis and autophagy via the PI3K/Akt/mTOR/p70S6K pathway in human non-small cell lung cancer cells.Biochemical and biophysical research communications2015name in abstract: HVJ-E
PMID 23784981IPS-1 plays a dual function to directly induce apoptosis in murine melanoma cells by inactivated Sendai virus.International journal of cancer2014name in abstract: HVJ-E
PMID 24371227Accumulation of cytosolic calcium induces necroptotic cell death in human neuroblastoma.Cancer research2014name in abstract: HVJ-E
PMID 24629697A novel photodynamic therapy for drug-resistant prostate cancer cells using porphyrus envelope as a novel photosensitizer.Photodiagnosis and photodynamic therapy2014name in abstract: HVJ-E
PMID 25023327Systemic administration of platelets incorporating inactivated Sendai virus eradicates melanoma in mice.Molecular therapy : the journal of the American Society of Gene Therapy2014name in abstract: HVJ-E
PMID 25073909Induction of apoptosis in hormone-resistant human prostate cancer PC3 cells by inactivated Sendai virus.Biomedical and environmental sciences : BES2014name in abstract: HVJ-E
PMID 2313443713-Cis retinoic acid can enhance the antitumor activity of non-replicating Sendai virus particle against neuroblastoma.Cancer science2013name in abstract: HVJ-E
PMID 23249543The study of novel DNA vaccines against tuberculosis: induction of pathogen-specific CTL in the mouse and monkey models of tuberculosis.Human vaccines & immunotherapeutics2013name in abstract: HVJ-E
PMID 23251005Systemic administration of a novel immune-stimulatory pseudovirion suppresses lung metastatic melanoma by regionally enhancing IFN-γ production.Clinical cancer research : an official journal of the American Association for Cancer Research2013name in abstract: HVJ-E
PMID 23734313The RIG-I/MAVS signaling pathway in cancer cell-selective apoptosis.Oncoimmunology2013name in abstract: HVJ-E
PMID 23886549Anti-tumor effects of inactivated Sendai virus particles with an IL-2 gene on angiosarcoma.Clinical immunology (Orlando, Fla.)2013name in abstract: HVJ-E
PMID 24157924Recent advances and developments in the antitumor effect of the HVJ envelope vector on malignant melanoma: from the bench to clinical application.Cancer gene therapy2013name in abstract: HVJ-E
PMID 21443915Virosome: a novel vector to enable multi-modal strategies for cancer therapy.Advanced drug delivery reviews2012name in abstract: HVJ-E
PMID 22894526In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.Journal of biomedical optics2012name in abstract: HVJ-E
PMID 23014529TRAIL and Noxa are selectively upregulated in prostate cancer cells downstream of the RIG-I/MAVS signaling pathway by nonreplicating Sendai virus particles.Clinical cancer research : an official journal of the American Association for Cancer Research2012name in abstract: HVJ-E
PMID 23066541In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.Journal of biomedical optics2012name in abstract: HVJ-E
PMID 23085849In vitro investigation of efficient photodynamic therapy using a nonviral vector; hemagglutinating virus of Japan envelope.Journal of biomedical optics2012name in abstract: HVJ-E
PMID 23122307Inactivated Sendai virus suppresses murine melanoma growth by inducing host immune responses and down-regulating β-catenin expression.Biomedical and environmental sciences : BES2012name in abstract: HVJ-E
PMID 21247507Cationized gelatin-HVJ envelope with sodium borocaptate improved the BNCT efficacy for liver tumors in vivo.Radiation oncology (London, England)2011name in abstract: HVJ-E
PMID 21546794Novel therapeutic vaccine: granulysin and new DNA vaccine against Tuberculosis.Human vaccines2011name in abstract: HVJ-E
PMID 21958872Knockdown of the tachykinin neurokinin 1 receptor by intrathecal administration of small interfering RNA in rats.European journal of pharmacology2011name in abstract: HVJ-E
PMID 21189152A non-replicating oncolytic vector as a novel therapeutic tool against cancer.BMB reports2010name in abstract: HVJ-E
PMID 19173282Efficient eradication of hormone-resistant human prostate cancers by inactivated Sendai virus particle.International journal of cancer2009name in abstract: HVJ-E
PMID 19424601A comparison of non-viral vectors for gene delivery to pancreatic beta-cells: delivering a hypoxia-inducible vascular endothelial growth factor gene to rat islets.International journal of molecular medicine2009name in abstract: HVJ-E
PMID 19578737Anti-tumor effects of fusion cells of type 1 dendritic cells and Meth A tumor cells using hemagglutinating virus of Japan-envelope.International journal of oncology2009name in abstract: HVJ-E
PMID 19675593Highly efficient eradication of intracranial glioblastoma using Eg5 siRNA combined with HVJ envelope.Gene therapy2009name in abstract: HVJ-E
PMID 17602226Intratumoral injection of inactivated Sendai virus particles elicits strong antitumor activity by enhancing local CXCL10 expression and systemic NK cell activation.Cancer immunology, immunotherapy : CII2008name in abstract: HVJ-E
PMID 17653716New potential therapy for orthotopic bladder carcinoma by combining HVJ envelope with doxorubicin.Cancer chemotherapy and pharmacology2008name in abstract: HVJ-E
PMID 18221753Efficient delivery of antibody into living cells using a novel HVJ envelope vector system.Journal of immunological methods2008name in abstract: HVJ-E
PMID 18248320Applications of Hemagglutinating Virus of Japan in therapeutic delivery systems.Expert opinion on drug delivery2008name in abstract: HVJ-E
PMID 18358837Sendai virus F glycoprotein induces IL-6 production in dendritic cells in a fusion-independent manner.FEBS letters2008name in abstract: HVJ-E
PMID 18813894Percutaneous nonviral delivery of hepatocyte growth factor in an osteotomy gap promotes bone repair in rabbits: a preliminary study.Clinical orthopaedics and related research2008name in abstract: HVJ-E
PMID 17149789Rapid transport of plasmid DNA into the nucleolus via actin depolymerization using the HVJ envelope vector.The journal of gene medicine2007name in abstract: HVJ-E
PMID 17210703Inactivated Sendai virus particles eradicate tumors by inducing immune responses through blocking regulatory T cells.Cancer research2007name in abstract: HVJ-E
PMID 17316929Immunisation of male mice with a plasmid DNA vaccine encoding gonadotrophin releasing hormone (GnRH-I) and T-helper epitopes suppresses fertility in vivo.Vaccine2007name in abstract: HVJ-E
PMID 17377741Preparation and evaluation of gene-transfected cultured skin as a novel drug delivery system for severely burned skin.Pharmaceutical research2007name in abstract: HVJ-E
PMID 17892442Development of tissue-targeting hemagglutinating virus of Japan envelope vector for successful delivery of therapeutic gene to mouse skin.Human gene therapy2007name in abstract: HVJ-E
PMID 18040151[Anticancer immunotherapy using inactivated Sendai virus particles].Uirusu2007name in abstract: HVJ-E
PMID 16488483Simple and highly efficient method for transient in vivo gene transfer to mid-late pregnant mouse uterus.Journal of reproductive immunology2006name in abstract: HVJ-E
PMID 16610935Development of high-throughput functional screening of therapeutic genes, using a hemagglutinating virus of Japan envelope vector.Human gene therapy2006name in abstract: HVJ-E
PMID 16648574Targeted chemotherapy against intraperitoneally disseminated colon carcinoma using a cationized gelatin-conjugated HVJ envelope vector.Molecular cancer therapeutics2006name in abstract: HVJ-E
PMID 17048546Novel drug delivery system by surface modified magnetic nanoparticles.Journal of nanoscience and nanotechnology2006name in abstract: HVJ-E
PMID 17075769Transient local overexpression of human vascular endothelial growth factor (VEGF) in mouse feto-maternal interface during mid-term pregnancy lowers systemic maternal blood pressure.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme2006name in abstract: HVJ-E
PMID 17083992Enhancement of gene transfer activity mediated by mannosylated dendrimer/alpha-cyclodextrin conjugate (generation 3, G3).Journal of controlled release : official journal of the Controlled Release Society2006name in abstract: HVJ-E
PMID 15712245Biocompatible polymer enhances the in vitro and in vivo transfection efficiency of HVJ envelope vector.The journal of gene medicine2005name in abstract: HVJ-E
PMID 15763165Direct in vivo protein transduction into a specific restricted brain area in rats.Neuroscience letters2005name in abstract: HVJ-E
PMID 16111768In vivo gene transfer into the mouse uterus: a powerful tool for investigating implantation physiology.Journal of reproductive immunology2005name in abstract: HVJ-E
PMID 17281548A viral envelope as a vehicle for tracer, drug, and gene delivery: initial biodistribution study using PET imaging.Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference2005name in abstract: HVJ-E
PMID 17282303A Viral Envelope as a Vehicle for Tracer, Drug, and Gene Delivery: Initial Biodistribution Study Using PET Imaging.Conference proceedings : ... Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual Conference2005name in abstract: HVJ-E

NIH grants

No confirmed grants yet.

Unconfirmed matches (1)

Found by a weaker match (an ambiguous or short name, or a name only in the abstract); not counted. Corrections welcome.

ProjectTitleOrganisationPIYearsLinked by
ZIAAI000432Regulation Of Immune Responses In Humans and in Experimental AnimalsNATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESSTROBER, WARREN2011–2011name in abstract: HVJ-E

Notes

Hemagglutinating virus of Japan envelope: inactivated, replication-incompetent Sendai virus particles given intratumorally, development code GEN0101. Included because it is a virus particle therapy dosed as an intratumoral anti-tumour agent, but it does not replicate, so the owner may prefer to exclude it from an oncolytic census.

How to cite

HVJ-E (AXP000130.1). The Abstractinator program registry, release 2026-11-17+2c46e992acfc. https://abstractinator.me/registry/AXP000130.html

Something wrong or missing? Suggest a correction (a GitHub issue; please link your evidence). Entry created 2026-11-11, updated 2026-11-11.